Zbisławska P, Cretti A, Szczygielski A, Skoczowska M
Department of Pathology of Pregnancy and Labour, Pomerianian Medical Academy, Szczecin, Poland.
Mater Med Pol. 1992 Apr-Jun;24(2):111-3.
The effect of tocolytic treatment with Salbupart and Partusisten in imminent premature labour on the serum levels of insulin, glucose, sodium and potassium was studied after 24 hours, and in some cases after 48 and 72 hours from the beginning of intravenous tocolytic treatment. The control group comprised healthy pregnant women receiving no tocolytic treatment. Statistical analysis showed that Salbupart and Partusisten raised the levels of insulin and glucose in the serum in pregnant women, but Salbupart increased more the insulin level and the raised levels of insulin and glucose persisted longer after Salbupart. No effect of these preparations on the serum levels of sodium and potassium in the studied pregnant women was noted.
研究了在即将发生早产时使用舒喘宁和羟苄羟麻黄碱进行宫缩抑制治疗24小时后，以及在某些情况下从静脉宫缩抑制治疗开始后48小时和72小时对胰岛素、葡萄糖、钠和钾血清水平的影响。对照组包括未接受宫缩抑制治疗的健康孕妇。统计分析表明，舒喘宁和羟苄羟麻黄碱可提高孕妇血清中的胰岛素和葡萄糖水平，但舒喘宁使胰岛素水平升高得更多，且舒喘宁治疗后胰岛素和葡萄糖升高的水平持续时间更长。未观察到这些制剂对所研究孕妇血清钠和钾水平有影响。
